-
IPHA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
-
Insider
- Institutional
- Shorts
Innate Pharma (IPHA)
Company Profile
Quarter (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
13F holders | Current |
---|---|
Total holders | 9 |
Opened positions | 8 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 560.24 mm |
Total shares | 7.42 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Bpifrance Participations | 7.19 mm | $15.81 mm |
Optiver Holding B.V. | 86.79 k | $198.75 mm |
Exchange Traded Concepts | 77.35 k | $177.13 mm |
MS Morgan Stanley | 43.52 k | $99.67 mm |
Citadel Advisors | 21.27 k | $48.70 mm |
UBS UBS | 8.41 k | $19.25 mm |
BCS Barclays | 307.00 | $1.00 k |
Rhumbline Advisers | 205.00 | $469.00 k |
Steward Partners Investment Advisory | 200.00 | $458.00 k |
Proequities | 0.00 | $0.00 |